A new study has revealed that men taking cholesterol –lowering medications are less prone of getting prostate cancer than those not on the drugs. The authors of the study have told that men taking statins were also less likely to have aggressive forms of prostate cancer -- especially those who had been taking the drugs for more than five years.

For the study, the researchers reviewed the medical records of more than 4,000 men who had a biopsy to test for prostate cancer at their institution between 2000 and 2007. All of those men were biopsied as doctors found possible signs of prostate cancer in their blood during their examination. According to their records, about 1,000 of those men were taking statins, and about 3,000 weren't. After their biopsies report, 55% of men taking statins were diagnosed with prostate cancer, compared to 58% who weren't taking statins.

However, the researchers have noted that they couldn’t take other diseases such as diabetes and heart disease into account, or other medications which men were taking. And because their study only consisted of men who were already having a prostate biopsy done, they don't know if the results can be generalized to other men.